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The atrazine metabolite diaminochlorotriazine suppresses LH
release from murine LβT2 cells by suppressing GnRH-induced
intracellular calcium transients
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Abstract
The primary metabolite of the herbicide atrazine (ATRA), diaminochlorotriazine (DACT), has
been suggested to cause disruption in the hypothalamic-pituitary-gonadal axis leading to inhibition
of luteinizing hormone (LH) release. DACT is a reactive electrophile known to form covalent
protein adducts both in vitro and in vivo following ATRA exposure and maybe targeting proteins
involved in GnRH-induced calcium signaling and subsequent LH release. To test this hypothesis,
LβT2 pituitary cells were exposed to 300 μM DACT for 24 hrs and examined by fluorescence
microscopy for GnRH-induced changes in intracellular calcium and LH release. LβT2 cells
exposed to DACT had markedly diminished GnRH-induced intracellular calcium transients and a
significant decreased LH release in response to GnRH. DACT appeared to cause a selective
decrease in caffeine-sensitive ryanodine receptor-operated calcium stores in LβT2 cells, rather
than in thapsigargin-sensitive ER calcium stores. This sensitivity correlated with the formation of
covalent protein adducts by DACT, as determined by mass spectrometry. ERp57 was identified by
mass spectrometry as a target of DACT adduction in the ER that could potentially mediate the
effects of DACT on inhibition of GnRH-induced calcium signaling and inhibition of LH release.
Intracellular calcium responses to GnRH and release of LH were restored in DACT-treated cells
with the addition of a calcium ionophore (A23187). These data suggest that DACT forms adducts
on proteins involved in calcium handling within the ER and that dysfunction in this critical
signaling system is associated with loss of normal sensitivity to GnRH and subsequent decreased
release of LH.
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Introduction
Atrazine (2-chloro-4-ethylamino-6-isopropyl- amino-s-triazine, (ATRA) a chlorotriazine
(Cl-TRI) herbicide is one of the most heavily used herbicides in the United States, an
estimated 76.4 million pounds are applied to crops each year. ATRA and other Cl-TRIs have
been reported to disrupt the estrous cycle in various laboratory rat strains.1 In other animal
studies, lifetime exposure to high levels of ATRA and other CL-TRIs cause premature
reproductive senescence. Normal reproductive aging results from a decrease in the
hypothalamic regulation of the luteinizing hormone (LH) secretion, the inability to produce
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enough LH to initiate ovulation causes persistent estrus.2 It has been shown in previous
studies that ATRA inhibits pulsatile LH release,3 which is attributed to premature
reproductive senescence. Additionally, ATRA has been shown to delay the onset of puberty
in both sexes4,5 and cause a reduction in basal testosterone levels.6,7,8 These effects may be
related to the atrazine induced suppression of LH release because it has been demonstrated
that the onset of puberty is associated with an increased nocturnal release of LH9,10,11 and
testosterone release from the testes is associated with an hourly release of LH.12,13
In the body, ATRA is extensively metabolized by P450 isozymes to mono-dealkylated
chlorinated metabolites 2-chloro-4-ethyl- amino-6-amino-1,3,5-triazine (ETHYL) and 2-
chloro- 4-amino-6-isopropylamino-1,3,5-triazine (ISO). Subsequent metabolism of these
dealkylated intermediates produces the di-dealkylated metabolite, diaminochlorotriazine
(DACT). Our group has recently shown that DACT is the major metabolite in the plasma
after dosing with ATRA, accounting for over 95% of the total chlorotriazine plasma area
under the curve (AUC). Thus DACT would be the likely metabolite to cause a disruption in
the hypothalamic-pituitary-gonadal axis.
We have previously reported that DACT is capable of forming covalent adducts with
numerous proteins in the pituitary of ATRA treated rats and in DACT treated LBT2 anterior
pituitary cells.14 Although the mechanisms responsible for the suppression of the LH surge
by ATRA are unknown, it is possible the LH signaling cascade is being disrupted by the
covalent modifications of key proteins by DACT. We postulated in the present studies that
DACT might inhibit GnRH-induced calcium signaling and thereby blunt the LH surge from
pituitary gonadotrophs, possibly through covalent modification of critical calcium regulatory
proteins.
Intracellular calcium (Ca2+) plays a critical role in the exocytosis of hormones and release
from the endoplasmic reticulum (ER) is an essential step in the signal transduction cascade
necessary for LH secretion from anterior pituitary gonadotrophs. The binding of GnRH to its
G-protein coupled receptor on anterior pituitary gonadotrophs begins the signaling cascade,
which causes a rapid release of calcium from ER stores that results in secretion of LH.15
Therefore, alterations in intracellular calcium release by modification of proteins within this
signaling pathway could be responsible for suppression of LH release. ERp57 is a protein
that has been identified as a target of DACT adduction,14 which also plays a role in calcium
signaling. ERp57 modulates the redox state of SERCA 2b thiols, which could provide
dynamic control of ER Ca2+ homeostasis.16
The data presented here demonstrate that DACT effectively suppresses GnRH-induced
intracellular calcium transients in LβT2 pituitary cells and that direct restoration of
intracellular calcium levels with a calcium ionophore is sufficient to restore LH release even
in DACT treated cells. ERp57 was identified by mass spectroscopy as a target of DACT




Diaminochlorotriazine (97.1% purity) was a gift from Syngenta Crop Science Inc.
(Greensboro, NC). The DACT adduct specific antibody was generated by Strategic
Biosolutions (Newark, DE), and the horseradish peroxidase-conjugated anti-rabbit antibody
was purchased from Santa Cruz Biotechnology, Inc, (Santa Cruz, CA). Methanol and acetic
acid were purchased from Mallinckrodt Baker Inc. (Paris, KY). Acetonitrile, bromophenol
blue, Tween-80, and ammonium bicarbonate were acquired from Fisher Chemical Company
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(Fair Lawn, NJ). Proteomic-grade porcine trypsin, iodoacetamide (IAA), Tris-HCl, glycerol,
CHAPS, urea, triflouroacetic acid, sodium citrate, hydrogen peroxie, trtiton-X-100 agarose,
and Pefabloc SC were purchased from Sigma Chemical Co. (St. Louis, MO). Sypro Ruby,
acrylamide, sodium dodecylsulfate (SDS), KCl, MgCl2, dithiothreitol (DTT), Tris-base,
mineral oil, and glycine were purchased from Bio-Rad Laboratories (Hercules, CA).
LβT2 Cell Culture DACT Exposures
LβT2 immortalized murine anterior pituitary cells were cultured in a T-150 flask with
complete Dulbelco's modified essential medium (DMEM) containing 4.5 g/l of glucose,
supplemented with 10% fetal bovine serum and 1% Pen/Strep (Media Tech, Herndon VA).
Cultures were grown in a humidified environment with 95% air and 5% CO2 at 37 °C to
80% confluence and then split into 4 treatment groups (N=5), which were grown on 60 mm
culture dishes. The four treatment groups were exposed to DMSO (DACT vehicle control),
300 μM DACT, 300 μM DACT/25 μM A23187, and 300 μM DACT/0.25% DMSO
(A23187 vehicle control). All cells were primed with 10 nM GnRH in the media for 15
mins, 4 times a day for 3 days. 12 h following the final priming with GnRH, three of the
treatment groups were then exposed to 300 μM DACT in DMEM and the 4th to DMSO in
DMEM (control) for 24 h.17 The cells were then rinsed with PBS and covered with 1.8ml of
Earl's buffered salt solution containing 1.75 mM CaCl2 (EBSS-Ca+2). 10nM GnRH alone or
in combination with 25 μM A23187 or DMSO was spiked into the EBSS-Ca+2 media for 3
mins and then the media was removed and frozen in liquid nitrogen for radioimmunoassy
(RIA) analysis. LH in the EBSS-Ca+2 media were analyzed by RIA at the Colorado State
University Endocrinology Laboratory as previously described.18 The remaining cells were
rinsed with DMEM followed by PBS and then scraped from the flask into 15-ml conical
tube. Tubes were centrifuged for 10 min at 14,000 rpm (16,000g) to form a tight cell pellet,
snap frozen with liquid nitrogen, and stored at -80° C until analysis.
Cell Microsomal Fractionation
LβT2 cell pellets were fractionated into cytoplasmic, microsomal, nuclear, and cytoskeleton
fractions with a Calbiochem ProteoExtract® Subcellular Proteome Extraction Kit (San
Diego, CA) following manufactures protocols. Proteins from the microsomal fraction were
precipitated with the Bio-Rad 2-D Clean-up Kit (Hercules, CA) following the
manufacturer's protocols and dissolved by sonication in 400 μl of rehydration buffer (8M
urea, 0.3% w/v DTT, 2% w/v CHAPS, pH 3-10 buffer, bromophenol blue).
Identification of DACT Adducted ERp57 in Microsomal Fractions
DACT adducted ERp57 was identified in the microsomal fraction by 2DE/Western blotting
followed by mass spectral analysis of targeted protein spots. For the first dimension
(isoelectric focusing) of the 2DE, the microsomal fraction (200 μl) was pipetted into a
rehydrating tray, a 7 cm immobilized pH gradient (IPG) strip, pH 5-8 (Bio-Rad, Hercules,
CA), was placed on the sample solution, and the strip was allowed to rehydrate passively for
at least 12 h. Using a Protean IEF Cell (Bio-Rad, Hercules, CA), the protein mixture was
focused using the voltage program of an increase from 0 to 500 V over 1 min, 500 to 3500
over 5 h, and steady exposure to 3500 V for 17.5 h. For the second dimension (SDS-PAGE)
separation, the IPG strip was removed from the focusing tray, reduced in 2% w/v DTT in
equilibration buffer (6 M urea, 30% v/v glycerol, 2% w/v SDS, 24 mM Tris-HCl) for 15
min, followed by alkylation in 2.5% w/v IAA in equilibration buffer for 5 min. The IPG
strip was placed on a slab gel (12% polyacrylamide) and proteins separated for 1.5 h at 200
V in a Mini-Protean III cell (Bio-Rad, Hercules, CA). 2-D gels were either stained with
Sypro Ruby for protein detection or subjected to Western blotting for immunodetection of
DACT-adducted proteins as previously described.14 For protein detection, the gel was
stained in 100 ml of Sypro Ruby stain for 2 hours and then destained with 10% methanol/
Dooley et al. Page 3













7% acetic acid. Stained proteins were visualized with 320 nm UV light using a BioChemi
Bioimaging system (UVP, Upland, CA) and the image saved for comparison with Western
blotting results. Protein spots from the Western blot were matched to spots on Sypro-stained
gels using the Delta 2D 3.6 (Decodon, Greifswald, Germany) gel image analysis program.
Spot patterns were matched between the gel and Western blot first by automation creating a
fusion image, followed by manual warping to align spots. Matched protein spots thought to
be ERp57 based on mass and isoelectric point were digested with trypsin and analyzed with
MALDI TOF/TOF mass spectrometry as previously described.14 The combined MS and
MS/MS spectra for each spot were searched using the Mascot (version 2.2) database search
engine against the Rattus (Taxonomy ID 101144) entries in Swiss-Prot (version 51.6)
database containing 5769 sequence entries. Parameters used in the database search were:
peptide mass tolerance of 0.15 Da, fragment ion mass tolerance of 0.8 Da, trypsin peptides
allowing for 1 missed cleavage, variable modifications of cysteine carbamidomethylation
and methionine oxidation.
LBT2 Cell Culture for Calcium Imagining
Immortalized LβT2 anterior gonadotrophs (Courtesy of Dr. Colin Clay, Colorado State
University) were cultured in DMEM media with L-glutamine, supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 50 units/mL penicillin, 50 ng/mL streptomycin, and
100 ng/mL neomycin (PSN) at 37 °C, 5% CO2 in a humidified atmosphere. Cells were
grown in 60 mm culture dishes for protein expression studies or subcultured onto FBS-
coated 2-well borosilicate chambered coverglass slides (Thermo-Fischer, Rochester, NY).
Cells were allowed to adhere for 48 hr prior to any treatments and then phenotypically
primed with 10 nM GnRH for 15 min every 1.5 hr, 4 times a day for 3 days. Approximately
400,000 LβT2 cells/well were plated onto chambered coverglass slides for imaging studies.
Intracellular Calcium Imaging
To detect changes in intracellular calcium, LβT2 cells were incubated with 2 μM Fluo-4-
acetylmethylesther (AM) (Invitrogen, Carlsbad, CA) for 15 min at 37 ºC in culture medium
under a humidified atmosphere at 5% CO2. Cells were then transferred to imaging medium
(Earl's buffered salt solution, EBSS) containing 1.75 mM CaCl2 (EBSS+Ca2+). For
experiments employing calcium-free media, EBSS was supplemented with 2 mM EGTA
instead of CaCl2 (EBSS-Ca2+). Cells were mounted on the stage of a Zeiss 200M inverted
fluorescence equipped with a DG-4 xenon excitation source (Sutter Instruments, Novato,
CA) and ORCA-ER cooled interline charge-coupled device camera (Hamamatsu Photonics,
Hamamatsu City, Japan). Images were acquired every 10 sec for 5 min and various
pharmacologic agonists were added at the 30 sec time point (10 nM GnRH, 2 μM
thapsigargin or 10 mM caffeine). Images of Fluo-4 fluorescence were detected at 490 nm
excitation/515 nm emission through a 20× NeoFluor air objective. Data were analyzed as the
mean background-subtracted fluorescence intensity of each cell normalized to the intensity
of the first image (F/F0). Both data acquisition and analysis were performed using Slidebook
software (Version 4.0, Intelligent Imaging Innovations, Denver, CO). Cells utilized for the
DACT portion of the experiments were treated with 300 μM DACT (96.8% pure, Syngenta
Corporation) for 24 hr following the final GnRH priming on day 3. Minimums of 500 – 800
cells were imaged per treatment group over at least 3 independent experiments.
Radioimmunoassay for Luteinizing Hormone (LH)
LβT2 cells were cultured in 60 mm tissue culture dishes to 80-85% confluency and primed
with GnRH as described above. After priming, cells were exposed to 300 μM DACT or
vehicle control (DMSO) for 24 hr. The cells were then rinsed gently with PBS and 1.8 mL
of EBSS-Ca2+ was added. 10 nM GnRH was then added to the cells for 3 min, followed by
removal of the EBSS-Ca2+ which was then frozen at -80° C for LH RIA. RIA was
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performed by the Colorado State University Endocrinology Laboratory as previously
described.18
Statistical Analysis
Multiple groups were analyzed by one-way ANOVA and Tukey's post-hoc test. Two-group
comparisons were analyzed the Students t-test. Differences were considered significant at
p<0.05. Data were analyzed using Prism software (v4.0a, Graphpad Software, Inc., San
Diego, CA). Differing letters (a, b, c, etc) in graphs indicate significant differences between
groups. Significance was set at p<0.05.
Results
Identification of DACT Adducted ERp57 in Microsomal Fractions
LβT2 cells exposed to 300 μM DACT showed a representative 2DE spot pattern seen in
Figure 1A. Western Blots of these gels using a DACT adduct specific antibody showed
several DACT modified proteins in the 57kDa/5.8 IP range (Figure 1B), while blots from
DMSO exposed control cells showed no spots (Figure 1C). MS analysis of these spots
identified two as ERp57, again with slightly different isoelectic points suggesting
differential post-translational modifications. Proteins spots identified as DACT adducted
ERp57 in LβT2 cells exposed to DACT are listed in Table 1, along with Mascot protein ion
scores and cutoffs, and sequence coverage for each identified protein.
GnRH Dependent Intracellular Calcium Imaging
The effect of DACT on GnRH-induced intracellular Ca2+ levels (Ca2+i) in LβT2 cells was
examined in Figure 2. Following pretreatment with 300 μM DACT for 24 hrs, LβT2 cells
were stimulated with 10 nM GnRH and relative changes in Ca2+i detected by wide-field
fluorescence microscopy. Addition of GnRH produced a rapid rise in Ca2+i in control LβT2
cells that was strongly attenuated by pretreatment with DACT. The amplitude of the initial
Ca2+i peak was decreased but the sustained or ‘plateau’ phase of the transient remained
unchanged (Figure 2A). Quantification of fluorescence intensity (Figure 2B) demonstrated a
significant decrease in the average maximum amplitude of GnRH-induced Ca2+i transients
in DACT treated LβT2 cells, relative to vehicle treated control cells.
To examine potential causes of DACT-induced inhibition of GnRH-dependent Ca2+
signaling, releasable Ca2+ from intracellular stores was evaluated in Figure 3. LβT2 cells
primed by GnRH exposure were exposed for 24 hrs to 300 μM DACT and examined for
changes in Ca2+i following stimulation with either 10 μM thapsigargin (Tg) or 5 mM
caffeine to induce release of Ca2+ release from Tg- or ryanodine receptor-dependent ER
stores, respectively. There was no difference in Tg-induced release of ER Ca2+ between
control and DACT treated cells (Figure 3A,B), whereas caffeine-induced Ca2+ release from
ryanodine receptor-sensitive ER stores was significantly decreased (Figure 3C,D).
To determine whether augmenting Ca2+i could reverse the effects of DACT on GnRH-
induced LH release, DACT-treated LβT2 cells were examined for changes in Ca2+i induced
by increasing concentrations of the Ca2+ ionophore, A23187 (Figure 4). Although DACT-
pretreatment abolished the effects of GnRH on Ca2+i transients, stimulation with 10 and 25
nM A23187 still resulted in a rapid increase in Ca2+i in DACT-pretreated LTβ2 cells (Figure
4A). Quantification of the maximum amplitude of A23187-induced Ca2+i transients (Figure
4B) revealed a dose-dependent increase in the peak amplitude of Ca2+i transients similar to
that induced by GnRH in control LTβ2 cells. GnRH-induced release of LH was also
examined in control and DACT-pretreated LTβ2 cells by radioimmunoassay (Figure 4C).
GnRH-induced release of LH was inhibited in LβT2 cells exposed to 300 μM DACT for 24
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hrs and this effect was reversed by increasing Ca2+i through stimulation with 25 nM
A23187.
Discussion
DACT is the major metabolite in the plasma shortly after dosing with ATRA19 and could
cause a disruption in the hypothalamic-pituitary-gonadal axis leading to the numerous
abnomalites observed following ATRA exposure in the rodent model. DACT is reactive
towards exposed cysteine residues in vitro forming stable covalent adducts through a non-
enzymatic nucleophilic substitution reaction at the chlorine moiety.20 Numerous DACT-
adducted proteins have been identified in the pituitary and hypothalamus in previous studies
with ATRA exposed rodents suggesting widespread protein modification.14,21 Nearly all of
the identified modified proteins share the common characteristic of exposed cysteine
residues. ERp57 was one of these proteins that was found to be modified by DACT in both
the pituitary and hypothalamus following in vivo and in vitro ATRA exposures.
ERp57 is an oxidoreductase found in the endoplasmic reticulum (ER) of cells, where its
exact function is not completely understood. It has been shown to be involved in formation
of disulphide bonds and folding glycoproteins when associated with calnexin and
careticulin,22,23 as well as in the redox modulation of SERCA 2b (calcium ATPase)
providing dynamic control of ER calcium homeostasis.16 ERp57 contains two redox active
Cys-Gly-His-Cys motifs (Cys-57, 60, 406, 409) that forms mixed disulfide bonds with
substrate protiens. SERCA 2b contains two conserved cysteine residues exposed to the
lumen of the ER (Cys 875 and Cy887). Formation of a disulphide bond between ERp57 and
these lumen cysteine residues of SERCA 2b has been shown to disrupt calcium cycling
consistent with inhibition of the pump.16 These Cys residues are potential targets for DACT
and it is possible that alkylation by DACT could prevent the ERp57/SERCA 2b interaction
and thereby reduce dynamic control of calcium homeostasis.
Using cellular fractionation procedures, we were able to isolate proteins from the
microsomal fraction of LβT2 cells exposed to DACT at concentrations shown to disrupt LH
secretion. From this isolated microsomal fractions, we were able to identify ERp57 as a
target of DACT through immunoreactivity and identification with mass spectrometry (Table
1). This identification of DACT adducted ERp57 in the lumen of the ER indicates that the
ERp57 interaction and possible control of SERCA 2b could be compromised with DACT
exposure. The resulting disruption of calcium homeostatisis could be of significant
detrimental consequence and explain the suppression of LH release from murine LβT2 cells
by suppressing GnRH-induced intracellular calcium transients.
The data in Figure 2 indicate that the capacity of GnRH to induce Ca2+ transients in LβT2
cells is dramatically blunted by DACT. This inhibition closely correlates with decreased
release of LH, suggesting that the mechanism by which DACT inhibits LH release in this
cell type involves a decreased capacity to mobilize calcium from intracellular stores. This is
supported by the data in Figure 2A demonstrating that only the peak Ca2+ levels were
suppressed by DACT, whereas steady state levels remained similar to control cells minutes
after the initial high amplitude transient subsided. It is therefore unlikely that capacitive
calcium entry from extracellular sources is compromised by DACT but rather that
mobilization of calcium from intracellular stores is the likely site of inhibition of the GnRH-
induced Ca2+i transient.
To test this hypothesis, we used selective pharmacologic stimulants for the two major pools
of ER calcium in control and DACT-treated cells (Figure 3). Releasable Ca2+ from
thapsigargin-sensitive ER stores was not inhibited by DACT, whereas DACT caused a
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significant decrease in ryanodine receptor-releasable ER calcium stores following
stimulation with 5 mM caffeine. These data identify ryanodine receptor-linked ER calcium
stores as a direct target of DACT in LβT2 cells and suggest that loss of mobilization from
this intracellular pool of calcium may underlie the capacity of DACT to inhibit release of
LH in response to GnRH signaling. GnRH binding to metabotropic receptors elicits
activation of phospholipase C and rapid mobilization of Ca2+ through IP3 receptors on the
ER, which are tightly linked to regulatory proteins such as ERp44, ERp57 and Ero1alpha
that mediate rapid and reversible flux of calcium through the ER.24 It is therefore plausible
that ERp57 or other proteins in the pathway regulating ryanodine receptor-mediated storage
or uptake of calcium are inhibited by DACT.
The functional consequence of restoring intracellular levels in DACT treated cells was
examined using the calcium ionophore A23187. The data in Figure 4 indicate that exposure
to low nanomolar doses of A23187 was sufficient to cause rapid, dose-dependent increases
in Ca2+ in LβT2 cells that were equivalent in amplitude to native transients induced by
stimulation with GnRH, even after pretreatment with DACT. Moreover, A23187 stimulation
resulted in dose-dependent increases in LH in DACT treated cells similar to untreated
control cells (Figure 4C). These data strongly support that impaired intracellular Ca2+
release is a fundamental mechanism underlying the capacity of DACT to inhibit GnRH-
induced LH release in LβT2 cells. Moreover, because A23187-stimulated cells release
similar levels of LH as untreated control cells, it is unlikely that reduced production of LH
by pituitary gonadotrophs is the cause of the blunted LH surge in response to exposure to
ATRA in experimental animals. The capacity of DACT-treated LβT2 cells to release LH
upon stimulation with A23187 also suggests that calcium-dependent vesicular release of LH
is not impaired, further implicating ryanodine receptor-linked ER calcium stores as a critical
target of DACT in this cell type.
In summary, the results of in vitro experiments presented herein argue that in part, the
mechanism of action for previously observed reduction of LH levels in experimental
animals could involve disruption of pituitary calcium signaling associated with protein
adduction (ERp57) by the reactive ATRA metabolite DACT. Since ERp57 has previously
been found to be modified by DACT in both the pituitary and hypothalamus following in
vivo ATRA exposures,14,21 we propose that adduction of the ERp57 protein interferes with
regulatory networks associated with receptor-mediated storage and/or calcium uptake, which
in turn results in LH suppression. Moreover, preliminary unpublished studies conducted in
ATRA treated female SD rats have initially confirmed that ATRA is capable of blunting LH
release from perifused hemi-pituitary fragments challenged with 100 nM GnRH and 200
mM KCL further confirming that there is a direct effect of ATRA (via DACT) on the
pituitary. However, further animal studies will be needed to confirm our in vitro findings
using LβT2 cells as well as the above described initial unpublished observations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. DACT bind to ERp57 localized in the ER of LβT2 cells
(A) 2DE of Sypro Ruby-stained water-soluble proteins from LβT2 cells exposed to 300 μM
DACT within the 50-75 kDa and 5-6 isoelectric point range. (B) 2DE Western blots for
DACT adducted proteins in LβT2 cells exposed to 300 μM DACT and (C) 2DE western
blots showing no adducted proteins in unexposed LβT2 cells. Numbering corresponding to
protein identifications in Table 1.
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Figure 2. Pretreatment with DACT blunts GnRH-induced intracellular calcium transients in
LβT2 cells
LβT2 cells were phenotypically primed by exposure to GnRH as described in Materials and
Methods and exposed to vehicle control (DMSO) or DACT (300 μM) for 24 hrs prior to
calcium imaging. Intracellular calcium (Ca2+i) was detected using Fluo-4-AM and
fluorescence images were collected at 10 Hz. Following baseline acquisition for 30 sec,
GnRH was added to induce Ca2+i transients. (A) Representative traces showing the time
course of GnRH-induced Ca2+i transients in in control and DACT-treated LβT2 cells. (B)
Quantification of the maximal amplitude of GnRH-induced Ca2+i transients indicates that
DACT pretreatment potently suppresses Ca2+i transients in LβT2 cells. Data were combined
from 3 independent experiments, averaging 700 - 800 cells total per experimental group.
(*p<0.05)
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Figure 3. DACT selectively depletes ER calcium stores in LβT2 cells
LβT2 cells primed by GnRH exposure were exposed for 24 hrs to 300 μM DACT or vehicle
control (DMSO) and examined for changes in intracellular Ca2+ following stimulation with
either 10 μM thapsigargin (Tg) or 5 mM caffeine. (A,B) Tg-induced release of Ca2+ from
ER stores was unaffected in LβT2 cells treated with DACT, relative to vehicle-treated
control cells. (C,D) Caffeine-induced release of Ca2+ from ryanodine receptor-sensitive
stores was reduced following treatment with 300 μM DACT. Data were combined from 3
independent experiments, averaging 500 - 600 cells total per experimental group. (*p<0.05)
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Figure 4. Restoration of intracellular calcium levels reverses the effects of DACT on GnRH-
induced release of LH
(A) LβT2 cells were exposed to DACT or vehicle control (DMSO) for 24 hrs and examined
for changes in Ca2+i transients following stimulation with the Ca2+ ionophore, A23187 (0,
10, and 25 nM). (B) Quantification of the average maximum amplitude of A23187-induced
Ca2+i transients indicates a dose-dependent increase in Ca2+i in DACT-treated cells. (C) LH
levels were determined by radioimmunoassay (RIA) in cell culture supernatants following
stimulation with GnRH. GnRH-induced release of LH was inhibited in LβT2 cells were
exposed to DACT but was restored upon stimulation with 25 A23187. Data were combined
from 3 independent experiments, averaging 500 - 600 cells total per experimental group
(A,B) or from 5 - 7 independent cell cultures. (*Different from control, p<0.05. **Different
from control and 10 nM A23187, p<0.05)
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